Presentation by Dr Angel Kunchev, Bulgarian Ministry of Health, on implementation in Bulgaria of the WHO Guide to Tailoring Immunization Programmes (TIP), at WHO/Europe Immunization Programme Managers Meeting, Antalya, Turkey, March 2014
Workshop 7 - Brainstorming & Policy Development session: Prevention
"Presentation of the International Federation for Spina
Bifida and Hydrocephalus’ primary prevention study"
Pierre Mertens, International Federation for Spina Bifida and Hydrocephalus (IF)
Workshop 7 - Brainstorming & Policy Development session: Prevention
"Presentation of the International Federation for Spina
Bifida and Hydrocephalus’ primary prevention study"
Pierre Mertens, International Federation for Spina Bifida and Hydrocephalus (IF)
Beryl Pilkington, RN, PhD, School of Nursing, Faculty of Health, York University in Toronto, presented at AMREF's Coffeehouse Speaker Series on global development on the intersection of health and development with specific focus on the community level in the Dadaab refugee camps. The coffeehouse speaker series looks at international development and global health, specifically focusing on Africa.
C-Change (Communication for Change) is a USAID-funded program to improve the effectiveness and sustainability of social and behavior change communication (SBCC) as an integral part of development efforts. C-Change focuses on malaria, HIV and AIDS, and family planning/reproductive health.
C-Change works with USAID and the President's Malaria Initiative (PMI) to prevent and control malaria in several PMI target countries, including Ethiopia, Kenya, Mozambique, Sao Tome and Principe, as well as others.
On September 13, 2010, C-Change and MCHIP facilitated a narrated presentation of the work of two PMI grantees, Concern Universal and HealthPartners, via a webinar. Participants included Save the Children, USAID, CDC, IFPH, and others.
For more information, please visit: http://www.c-changeprogram.org/
This presentation was conceptualised and made by me as a part of my Summer training project work. The project was a real time activity carried out by the Public Health division of ASTRON Hospital & healthcare Consultants Pvt. Ltd.
Presentation given by Dr Lo Veasnakiry at the 3rd Cambodian Health Researchers' Forum held at the National Institute of Public Health in Phnom Penh, 20th January 2017.
Fast-track the end of AIDS in the EU - practical evidence-based interventions.
Presentation by: Annette Verster, WHO
In a two-day meeting under the auspices of the Maltese Presidency of the Council of the European Union (30-31 January 2017), HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
Beryl Pilkington, RN, PhD, School of Nursing, Faculty of Health, York University in Toronto, presented at AMREF's Coffeehouse Speaker Series on global development on the intersection of health and development with specific focus on the community level in the Dadaab refugee camps. The coffeehouse speaker series looks at international development and global health, specifically focusing on Africa.
C-Change (Communication for Change) is a USAID-funded program to improve the effectiveness and sustainability of social and behavior change communication (SBCC) as an integral part of development efforts. C-Change focuses on malaria, HIV and AIDS, and family planning/reproductive health.
C-Change works with USAID and the President's Malaria Initiative (PMI) to prevent and control malaria in several PMI target countries, including Ethiopia, Kenya, Mozambique, Sao Tome and Principe, as well as others.
On September 13, 2010, C-Change and MCHIP facilitated a narrated presentation of the work of two PMI grantees, Concern Universal and HealthPartners, via a webinar. Participants included Save the Children, USAID, CDC, IFPH, and others.
For more information, please visit: http://www.c-changeprogram.org/
This presentation was conceptualised and made by me as a part of my Summer training project work. The project was a real time activity carried out by the Public Health division of ASTRON Hospital & healthcare Consultants Pvt. Ltd.
Presentation given by Dr Lo Veasnakiry at the 3rd Cambodian Health Researchers' Forum held at the National Institute of Public Health in Phnom Penh, 20th January 2017.
Fast-track the end of AIDS in the EU - practical evidence-based interventions.
Presentation by: Annette Verster, WHO
In a two-day meeting under the auspices of the Maltese Presidency of the Council of the European Union (30-31 January 2017), HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
الثلاثاء 22 مارس 2016: أحداث منتظرة
9.00 وزير الفلاحة يفتتح اليوم الوطني للاقتصاد في مياه الري/المعهد الوطني للعلوم الفلاحية بتونس
9.00 ندوة بعنوان" الوقاية من الأخطار المهنية في القطاع الفلاحي" / مقر المنظمة الفلاحية بالعاصمة
9.00 ملتقى وطني حول القيادات الشابة والاستراتيجية الوطنية للشباب/نزل" ROYAL THALASSA" بالمنستير
9.00 سفير المملكة المتحدة يشرف على اختتام أيام التحدي التونسية للمناظرات/ نزل البلاص بقمرت
9.00 ورشة دولية حول التربية على حقوق الإنسان: تحديات راهنة وأساليب مبتكرة"/ نزل المشتل بالعاصمة
9.00 جلسة عامة للمصادقة على مشاريع قوانين/ مقر مجلس النواب بباردو
10.00 وقفة احتجاجية للمجلس الجهوي للمنظمة التونسية للشغل بصفاقس/ أمام مقر الولاية
10.00 اجتماع المكتب التنفيذي الموسع لاتحاد الشغل/ مقر الاتحاد بالعاصمة
11.00 انطلاق اجتماع وزراء خارجية دول جوار ليبيا / نزل القولدن توليب بقمرت
11.00 ندوة صحفية لنقابة الأئمة التابعة لاتحاد الشغل/ مقر الاتحاد بالعاصمة
13.00 مؤتمر صحفي مشترك لوزراء خارجية دول جوار ليبيا / نزل القولدن توليب بقمرت
Health partners elluminate ppt_final_9.13.10CChangeProgram
C-Change (Communication for Change) is a USAID-fundd program to improve the effectiveness and sustainability of social and behavior change communication (SBCC) as an integral part of development efforts in malaria, HIV and AIDS, and family planning/reproductive health.
C-Change works with USAID and the President's Malaria Initiative (PMI) to prevent and control malaria in several PMI target countries, including Ethiopia, Kenya, Mozambique, Sao Tome and Principe, as well as others.
On September 13, 2010, C-Change and MCHIP facilitated a narrated presentation of the work of two PMI grantees, Concern Universal and HealthPartners, via a webinar. Participants included Save the Children, USAID, CDC, IFPH, and others.
For more information, please visit: http://www.c-changeprogram.org/
Presentation – The Issue-based Coalition on Health and Well-being
12 May 2017, Geneva, Switzerland
By Dr Zsuzsanna Jakab, WHO Regional Director for Europe
In cooperation with the Research and Evaluation Division of BRAC, Copenhagen Consensus Center organized roundtable discussions with an aim to figure out smarter solutions to the most problematic issues facing Bangladesh.
Workshop 6 - Brainstorming & Policy Development session: Training, information and education of MDs
"Feedback from the 15 National Conferences"
Christel Nourissier, EURORDIS
Reported measles cases for the period November 2020—October 2021 (data as of 02 December 2021).A monthly summary of the epidemiological data on selected vaccine-preventable diseases in the WHO European Region
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Tailoring immunization programmes in Bulgaria
1. WHO Guide “Tailoring Immunization
Programmes”:
introduction in Bulgaria and first results
WHO European Regional Meeting of National Immunization Programme Managers
Antalya, Turkey, 18 – 20 March 2014
Angel Kunchev, MD,
Chief State Health Inspector,
Ministry of Health of Bulgaria
Radosveta Filipova, MD,
Head, State Health Department,
Ministry of Health of Bulgaria
2. • Southeastern Europe – Balkan peninsula
• Territory 110 993 km2 ;
• 28 administrative regions, 263 municipalities
• Total population 7 563 710
• Urban areas population 70,17 %
• Ethnic structure:
• Bulgarians 84 %
• Turks 9,4 %
• Roma 4,7 %
• Other minorities (Armenians, Vlachs,
Jews etc.) 1,9 %
• Live births 80 956
• Birth rate 10.7/ 1000
• Infant mortality rate 9,0 / 1000 life births
• Natural growth - 3,5 / 1000
• Life expectancy 73,4 yr.
Source: National Center of Health Informatics,
Basic Statistic Information for 2011
3. What a TIP Approach means?
A pathway to understand what influences caregivers when
they consider whether or not to vaccinate their child and to detect
determinants providing opportunity, ability and motivation to
vaccinate or not.
Why especially Bulgaria was chosen?
The measles outbreak in Bulgaria 2009 – 2011
predominantly affected vulnerable groups of population and
pockets of non-immunized or partially immunized individuals at
subnational levels despite the national coverage for the first dose
of MMR vaccine was near 96%.
4. MEASLES CASES IN BULGARIA AFTER THE INTRODUCTION OF
MEASLES IMMUNIZATION, 1969
Source: National Centre of Infectious and Parasitic Diseases,
Bulgaria, 2013
5. NATIONAL IMMUNIZATION COVERAGE WITH MMR VACCINE IN
BULGARIA, 2001-2012
Year
VACCINE COVERAGE (%)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
MMR at
13 mos
90.1 92.1 95.5 94.7 96.2 95.7 96.0 95.9 96.1 96.5 94.5 93.7
MMR at
12 yrs
68.8 79.2 89.4 90.8 92.4 93.3 94.0 94.3 92.8 95.7 93.9 94.0
Source: National Centre of Infectious and Parasitic Diseases, Bulgaria, 2012
6. MEASLES OUTBREAK IN BULGARIA, 2009-2011
∞ Marinova L., Epidemiology of measles in Bulgaria during the elimination and prospects for effective surveillance. PhD thesis, Sept. 2012.
Total number
Number of Roma people
%
Measles cases 24 208 21 701 89.6
Deaths 24 22 91.7
7. VACCINATION STATUS OF MEASLES CASES IN BULGARIA, 2009-
2011
Number of
vaccine doses
Number of cases by age groups
Total
≤ 1 1-4 5-9 10-14 15-19 20-29 30+
0 3 301 1 368 266 145 120 42 20 5 262
1 18 2 085 2 174 1 259 541 69 20 6 166
2 3 107 188 329 518 80 13 1 238
No data 569 2 299 1 938 1 880 1 988 1 719 1 306 11 699
Total 3 891 5 859 4 566 3 613 3 167 1 910 1 359 24 365
8. LESSONS LEARNED
• The approach to a better measles control in Bulgaria should be focused
on the improvement of the routine immunization activities of
underserved Roma communities through better communication and
awareness of the community and permanent collaboration with the
Network of the Health Mediators and other NGOs.
• Because the level of vaccination coverage is very much depending on
the knowledge of the health care workers, different strategies and
trainings targeting health professionals should be implemented.
9. Health mediator – what does mean?
National network of Health mediators was established in 2007 in the frame
of a PHARE project and transferred after finishing the Project in a
municipality employees financed by the state budget.
General requirements for Job position
Education: Secondary school
Qualification: Completed specialized training course for a health
mediator, approved by the Ministry of Health or Diploma (Certificate) from a
Medical College
Languages: Knowledge of Romany/Turkish language is commendable
Additional requirements: Knowledge about the health and social
legislation and relevant national policies
Job description: Mediates the process of ensuring access to health
services of representatives of vulnerable minority groups
10. Major responsibilities
Work with clients: · Good knowledge and formulation of the problem;· Assessment of
the difficulties connected with the access to the respective services and elaboration of a
work plan on the case.
Facilitation of the process of access to services in the sphere of health care for
people, needing medical assistance:· Helps (accompanies, informs, clarifies, explains)
with the contacts between the GP and/or other medical experts and the patient.
Assistance in the communications with the Health Insurance Fund:· The health
mediator provides information on the necessity and significance of the services, provided
by the National Health Insurance Fund and helps with the filling in of the necessary
documentation.
Assistance with the communications with the Department for Social Assistance, the
State Agency for Child Protection and the Commission for Protection against
Discrimination:· The Mediator provides information about the functioning of these
institutions and facilitates the clients’ access to them.
Health education and prevention care for the population:· Consults the target group
on issues related to family planning and reproductive health;· Explains the benefits of
vaccinations and immunizations.
11. TIP Problem Statement - Bulgaria
• Health problem
• Potential
primary
audience
• Under-vaccination for childhood
diseases among vulnerable pockets
of the Bulgarian population,
evidenced by the 2009-2010measles
epidemic
• Health mediators who act as
gatekeepers for vaccination
communication, education, reminder
and access to health and social
services
• Caregivers/parents of children up to
3 years
12. Strategic activities 1
• Identify and share best
practices in health mediation
in the context of child
vaccination promotion
• Revise the job description
for health mediators and
include more attention to
maternal and child
health/immunization
• Use HM Internet platform to identify
best practices
www.zdravenmediator.net
• Organize regional/national
workshops to share best practices
• Identifying unregistered to local GP
children
• Provide them information on health
services available including
vaccinations and help them to take
decision
• Reminding parents for the time of
coming vaccinations
13. Strategic activities 2
• Increase competences of
health mediators in maternal
and child health and
Immunization
• Provide continuing
education to existing health
mediators
• Provide more hours in the current
curriculum of health mediators in
the field of MCH, CD protection
and immunizations
• Involve local GPs in the health
mediator training programme
• Upgrade the training with best
practices in interpersonal
communication and vaccination
promotion
14. Strategic activities 3
• Promote municipal level
relationships and
collaboration between
health mediators, social
workers, Regional Health
Inspectorates and GP’s
• Develop and disseminate
job aids for use by health
mediators
• Organize regional workshops to
improve inter-institutional
relationships and coordination –
Collect and disseminate best practices
at the municipal level
• Develop and disseminate reminder
posters, recall aids
• Develop a standard flip-chart (incl.
vaccination calendar, information on
VPD and benefits and value of
vaccination ) to guide “health-talks”
in the community
• Design standard module/plan for
holding a community “health-talk”
15. “LETS TALK ABOUT PROTECTION” PROJECT
This collaborative project aims to:
perform cultural adaptation of the European materials on immunizations;
facilitate the communication between healthcare providers (HCPs), Health
mediators (HMs) and parents on the topic of vaccination;
explain in simple language, graphics and pictures the benefits and risks from
immunization;
give answers to the most popular concerns that parents have towards
vaccination.
16.
17.
18. RESULTS AND WHAT COMES NEXT?
Increasing the number of Health Mediators of national level –
130 for 2013 in 71 municipalities, 150 for 2014 in 79
municipalities
Organize a national meeting in April 2014 with participation
of Health Mediators, epidemiologists and GP’s during the
EIW 2014
Develop and disseminate print materials on different languages
for Roma and refugees
19. Illegal migrants identified on the
Bulgarian-Turkish green, 2012 and 2013
4000 2012
3500
3000
2500
2000
1500
1000
500
0
2013